Benlysta 400 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9FB7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,811
Award facts
- Contract value 100% obligated
- $10,811.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,811.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 400 mg vials. The contract is set to complete by December 31, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order supports the Defense Health Agency and military healthcare systems' pharmaceutical supply requirements through AmerisourceBergen's comprehensive global pharmaceutical support vehicle. Benlysta (belimumab) is a specialized biologic medication primarily used in the treatment of systemic lupus erythematosus, reflecting the military healthcare system's need for advanced therapeutic agents. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies serving defense and veteran healthcare programs worldwide. The firm fixed-price structure and delivery order mechanism provide efficient procurement flexibility under the broader DLA pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26F9FB7?
SPE2DR26F9FB7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F9FB7 worth?
The government has obligated $10,811 on SPE2DR26F9FB7.
Is contract SPE2DR26F9FB7 an order under another contract?
Yes. SPE2DR26F9FB7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FB7 competed?
The extent of competition for SPE2DR26F9FB7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award